PREMIER HEALTH OF AMERICA IN (PHA.CA) Fundamental Analysis & Valuation

TSX-V:PHA • CA74052G1063

Current stock price

0.02 CAD
0 (0%)
Last:

This PHA.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PHA.CA Profitability Analysis

1.1 Basic Checks

  • In the past year PHA has reported negative net income.
  • In the past year PHA had a positive cash flow from operations.
  • In the past 5 years PHA reported 4 times negative net income.
  • Of the past 5 years PHA 4 years had a positive operating cash flow.
PHA.CA Yearly Net Income VS EBIT VS OCF VS FCFPHA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M -15M

1.2 Ratios

  • PHA has a Return On Assets of -36.89%. This is amonst the worse of the industry: PHA underperforms 83.33% of its industry peers.
Industry RankSector Rank
ROA -36.89%
ROE N/A
ROIC N/A
ROA(3y)-17.55%
ROA(5y)-9.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PHA.CA Yearly ROA, ROE, ROICPHA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

1.3 Margins

  • PHA has a worse Gross Margin (16.19%) than 75.00% of its industry peers.
  • PHA's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for PHA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.25%
GM growth 5Y-9.97%
PHA.CA Yearly Profit, Operating, Gross MarginsPHA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. PHA.CA Health Analysis

2.1 Basic Checks

  • PHA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for PHA remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, PHA has more shares outstanding
  • PHA has a worse debt/assets ratio than last year.
PHA.CA Yearly Shares OutstandingPHA.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
PHA.CA Yearly Total Debt VS Total AssetsPHA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • PHA has an Altman-Z score of -0.63. This is a bad value and indicates that PHA is not financially healthy and even has some risk of bankruptcy.
  • PHA has a Altman-Z score of -0.63. This is amonst the worse of the industry: PHA underperforms 83.33% of its industry peers.
  • PHA has a debt to FCF ratio of 3.49. This is a good value and a sign of high solvency as PHA would need 3.49 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.49, PHA is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.49
Altman-Z -0.63
ROIC/WACCN/A
WACC7.71%
PHA.CA Yearly LT Debt VS Equity VS FCFPHA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

2.3 Liquidity

  • PHA has a Current Ratio of 0.34. This is a bad value and indicates that PHA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.34, PHA is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.34 indicates that PHA may have some problems paying its short term obligations.
  • PHA's Quick ratio of 0.34 is on the low side compared to the rest of the industry. PHA is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.34
PHA.CA Yearly Current Assets VS Current LiabilitesPHA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. PHA.CA Growth Analysis

3.1 Past

  • PHA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.34%.
  • The Revenue for PHA has decreased by -42.83% in the past year. This is quite bad
  • The Revenue has been growing by 37.51% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-8.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.78%
Revenue 1Y (TTM)-42.83%
Revenue growth 3Y8.2%
Revenue growth 5Y37.51%
Sales Q2Q%-44.49%

3.2 Future

  • PHA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.43% yearly.
  • Based on estimates for the next years, PHA will show a small growth in Revenue. The Revenue will grow by 3.00% on average per year.
EPS Next Y-0.86%
EPS Next 2Y-0.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.25%
Revenue Next 2Y3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PHA.CA Yearly Revenue VS EstimatesPHA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
PHA.CA Yearly EPS VS EstimatesPHA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 -0.1 -0.15

More info and screens

Find the best growth stocksShow best growing peers

2

4. PHA.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • PHA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year PHA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PHA.CA Price Earnings VS Forward Price EarningsPHA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, PHA is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.09
EV/EBITDA N/A
PHA.CA Per share dataPHA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.43%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PHA.CA Dividend Analysis

5.1 Amount

  • PHA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHA.CA Fundamentals: All Metrics, Ratios and Statistics

PREMIER HEALTH OF AMERICA IN

TSX-V:PHA (4/1/2026, 7:00:00 PM)

0.02

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)05-19
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners42.81%
Ins Owner ChangeN/A
Market Cap1.11M
Revenue(TTM)87.67M
Net Income(TTM)-15.73M
Analysts40
Price Target0.2 (900%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.09
P/OCF 0.08
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)0.23
FCFY1147.72%
OCF(TTM)0.26
OCFY1309.41%
SpS1.58
BVpS-0.25
TBVpS-0.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -36.89%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.19%
FCFM 14.53%
ROA(3y)-17.55%
ROA(5y)-9.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.25%
GM growth 5Y-9.97%
F-Score3
Asset Turnover2.06
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.49
Debt/EBITDA N/A
Cap/Depr 22.6%
Cap/Sales 2.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z -0.63
F-Score3
WACC7.71%
ROIC/WACCN/A
Cap/Depr(3y)37.4%
Cap/Depr(5y)42.11%
Cap/Sales(3y)2.02%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.78%
EPS Next Y-0.86%
EPS Next 2Y-0.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-42.83%
Revenue growth 3Y8.2%
Revenue growth 5Y37.51%
Sales Q2Q%-44.49%
Revenue Next Year0.25%
Revenue Next 2Y3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-266.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-45.02%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1076.98%
FCF growth 3Y43.85%
FCF growth 5Y83.87%
OCF growth 1Y333.86%
OCF growth 3Y44.57%
OCF growth 5Y72.26%

PREMIER HEALTH OF AMERICA IN / PHA.CA Fundamental Analysis FAQ

What is the fundamental rating for PHA stock?

ChartMill assigns a fundamental rating of 2 / 10 to PHA.CA.


What is the valuation status of PREMIER HEALTH OF AMERICA IN (PHA.CA) stock?

ChartMill assigns a valuation rating of 2 / 10 to PREMIER HEALTH OF AMERICA IN (PHA.CA). This can be considered as Overvalued.


Can you provide the profitability details for PREMIER HEALTH OF AMERICA IN?

PREMIER HEALTH OF AMERICA IN (PHA.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for PHA stock?

The financial health rating of PREMIER HEALTH OF AMERICA IN (PHA.CA) is 2 / 10.